Sign in
SAVAW Stock Price, Chart, Stats & News
Cassava Sciences, Inc. Warrant
Save
Cassava Sciences, Inc. Warrant (SAVAW) is a dividend-paying stock with a current dividend yield of 0.00% as of Aug 19, 2024. It pays $0 per share over the trailing twelve months.
SAVAW chart
1M
3M
1Y
5Y
Loading chart...
About
Cassava Sciences, Inc. is a biotechnology firm currently in the clinical development stage, dedicated to discovering therapies for neurodegenerative disorders. Their key therapeutic asset is simufilam, a small molecule drug that has already completed its Phase 2b clinical evaluation. Furthermore, the company is advancing SavaDx, a diagnostic tool utilizing blood-based biomarkers for the early detection of Alzheimer's disease.
Similar securities
Based on sector and market capitalization
Report issue